Monitoring immunomodulation strategies in type 1 diabetes.
T cell exhaustion
antigen specific therapy
biomarkers
disease modifying treatment
type 1 diabetes
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
04
2023
accepted:
26
05
2023
medline:
26
6
2023
pubmed:
22
6
2023
entrez:
22
6
2023
Statut:
epublish
Résumé
Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease. Short-term treatment with agents targeting T cells, B cells and inflammatory cytokines to modify the disease course resulted in a short-term pause in disease activity. Lessons learnt from these trials will be discussed in this review. It is expected that effective disease-modifying agents will become available for use in earlier stages of T1D. Progress has been made to analyze antigen-specific T cells with standardization of T cell assay and discovery of antigen epitopes but there are many challenges. High-dimensional profiling of gene, protein and TCR expression at single cell level with innovative computational tools should lead to novel biomarker discovery. With this, assays to detect, quantify and characterize the phenotype and function of antigen-specific T cells will continuously evolve. An improved understanding of T cell responses will help researchers and clinicians to better predict disease onset, and progression, and the therapeutic efficacy of interventions to prevent or arrest T1D.
Identifiants
pubmed: 37346035
doi: 10.3389/fimmu.2023.1206874
pmc: PMC10279879
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1206874Informations de copyright
Copyright © 2023 Krishnamurthy, Lacorcia, Kay, Thomas and Mannering.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Immunol. 2011 Jan;138(1):117-26
pubmed: 21044870
JCI Insight. 2021 Nov 8;6(21):
pubmed: 34747368
Diabetes. 2011 Nov;60(11):2922-7
pubmed: 21896930
JCI Insight. 2021 Feb 8;6(3):
pubmed: 33351781
Eur J Immunol. 2022 Mar;52(3):372-388
pubmed: 35025103
N Engl J Med. 2019 Aug 15;381(7):603-613
pubmed: 31180194
J Immunol. 2006 Mar 1;176(5):2781-9
pubmed: 16493034
Diabet Med. 2018 Jun 16;:
pubmed: 29908076
Diabetes. 2015 Jan;64(1):172-82
pubmed: 25157096
Pediatr Diabetes. 2011 May;12(3 Pt 1):150-5
pubmed: 20522167
Clin Immunol. 2015 Nov;161(1):44-50
pubmed: 26122171
J Clin Invest. 2006 Dec;116(12):3258-65
pubmed: 17143333
Immunol Cell Biol. 2022 Jan;100(1):33-48
pubmed: 34668580
Diabetes. 2013 Nov;62(11):3901-8
pubmed: 23801579
PLoS One. 2011;6(12):e29008
pubmed: 22174945
JAMA. 2013 Jun 19;309(23):2473-9
pubmed: 23780460
J Clin Invest. 2004 Feb;113(3):451-63
pubmed: 14755342
J Clin Invest. 2015 Jan;125(1):448-55
pubmed: 25500887
Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224
pubmed: 33662334
Nat Med. 2016 Dec;22(12):1482-1487
pubmed: 27798614
Science. 2016 Feb 12;351(6274):711-4
pubmed: 26912858
J Clin Invest. 2017 Aug 1;127(8):2881-2891
pubmed: 28762987
Diabetes. 2012 Sep;61(9):2340-8
pubmed: 22721971
Lancet. 2011 Jul 23;378(9788):319-27
pubmed: 21714999
J Exp Med. 2006 Oct 30;203(11):2461-72
pubmed: 17030951
J Immunol Methods. 2005 Mar;298(1-2):83-92
pubmed: 15847799
Cell Metab. 2019 Mar 5;29(3):755-768.e5
pubmed: 30713109
Diabetologia. 2016 Jun;59(6):1153-61
pubmed: 27053235
Nat Immunol. 2023 Feb;24(2):267-279
pubmed: 36543958
Front Immunol. 2015 Aug 21;6:418
pubmed: 26347741
Diabetes. 2009 Oct;58(10):2285-91
pubmed: 19641142
Cell Metab. 2019 Mar 5;29(3):769-783.e4
pubmed: 30713110
J Clin Invest. 1980 Mar;65(3):592-601
pubmed: 6766467
J Exp Med. 2003 Jun 16;197(12):1635-44
pubmed: 12796471
J Autoimmun. 2005 Nov;25(3):235-43
pubmed: 16263242
J Exp Med. 2012 Jan 16;209(1):51-60
pubmed: 22213807
Diabetes. 2010 Jul;59(7):1721-30
pubmed: 20357361
J Clin Invest. 2018 Aug 1;128(8):3460-3474
pubmed: 29851415
J Clin Invest. 2008 Oct;118(10):3390-402
pubmed: 18802479
Lancet. 2013 Jun 1;381(9881):1905-15
pubmed: 23562090
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9317-22
pubmed: 20439719
Diabetes Care. 2014 Feb;37(2):453-9
pubmed: 24026563
Diabetes Care. 2011 Jul;34(7):1585-90
pubmed: 21610124
JCI Insight. 2016 Jul 7;1(10):e86065
pubmed: 27699217
Science. 2021 Jul 30;373(6554):510-516
pubmed: 34326232
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32251514
Diabetes Care. 2014 Apr;37(4):1069-75
pubmed: 24296850
Diabetes Care. 2004 Oct;27(10):2348-55
pubmed: 15451899
J Exp Med. 2005 Nov 7;202(9):1191-7
pubmed: 16260488
Diabetologia. 2021 May;64(5):1079-1092
pubmed: 33515070
Diabetes. 1997 Jan;46(1):34-9
pubmed: 8971078
Acta Diabetol. 2022 May;59(5):687-696
pubmed: 35098372
Diabetologia. 2021 Feb;64(2):313-324
pubmed: 33145642
Diabetes. 2011 Apr;60(4):1237-45
pubmed: 21307076
JAMA. 2015 Apr 21;313(15):1541-9
pubmed: 25898052
N Engl J Med. 2008 Oct 30;359(18):1909-20
pubmed: 18843118
J Immunol. 2021 Oct 15;207(8):1990-2004
pubmed: 34507949
J Immunol Methods. 2003 Dec;283(1-2):173-83
pubmed: 14659909
Lancet Diabetes Endocrinol. 2013 Dec;1(4):284-94
pubmed: 24622414
Front Immunol. 2020 Jun 09;11:1103
pubmed: 32582188
J Clin Invest. 2020 Jan 2;130(1):480-490
pubmed: 31815738
J Diabetes Res. 2018 May 24;2018:9391845
pubmed: 30009185
Diabetologia. 2004 Jan;47(1):149-50
pubmed: 14614561
Clin Exp Immunol. 2010 Mar;159(3):338-43
pubmed: 20059481
Diabetes. 2013 Nov;62(11):3766-74
pubmed: 23835333
Nature. 2005 May 12;435(7039):220-3
pubmed: 15889095
J Autoimmun. 2010 Jun;34(4):408-15
pubmed: 19931408
J Exp Med. 2003 Jul 7;198(1):63-9
pubmed: 12847137
N Engl J Med. 2012 Feb 2;366(5):433-42
pubmed: 22296077
Diabetes. 2008 May;57(5):1312-20
pubmed: 18305140
JAMA. 2017 Nov 21;318(19):1891-1902
pubmed: 29164254
Nat Immunol. 2004 Oct;5(10):1028-35
pubmed: 15378058
N Engl J Med. 2020 Nov 19;383(21):2007-2017
pubmed: 33207093
Diabetes Care. 2009 Jul;32(7):1244-9
pubmed: 19366957
Endocr J. 2010;57(11):991-6
pubmed: 20966598
N Engl J Med. 2009 Nov 26;361(22):2143-52
pubmed: 19940299
Pediatr Diabetes. 2018 May;19(3):410-419
pubmed: 29171140
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10732-10737
pubmed: 30275329
N Engl J Med. 2002 May 30;346(22):1692-8
pubmed: 12037148
Nature. 2005 May 12;435(7039):224-8
pubmed: 15889096
N Engl J Med. 2005 Jun 23;352(25):2598-608
pubmed: 15972866
Immunity. 2010 Apr 23;32(4):568-80
pubmed: 20381385
Nature. 2015 Jul 30;523(7562):612-6
pubmed: 26123020
Clin Exp Immunol. 2016 Jan;183(1):8-15
pubmed: 26313217
Diabetes Technol Ther. 2019 Feb;21(2):66-72
pubmed: 30657336
Diabetes. 2018 Aug;67(8):1471-1480
pubmed: 29937434
Horm Metab Res. 1999 May;31(5):340-4
pubmed: 10422732
Sci Transl Med. 2017 Aug 9;9(402):
pubmed: 28794283
Diabetes Care. 2013 Nov;36(11):3418-24
pubmed: 23863909
Diabetes. 2019 Jul;68(7):1366-1379
pubmed: 31221801
Diabetes. 2015 Mar;64(3):916-925
pubmed: 25249579
Nat Immunol. 2021 Dec;22(12):1590-1598
pubmed: 34811538
J Immunol. 2007 Nov 1;179(9):5785-92
pubmed: 17947651
Diabetes. 2021 Mar;70(3):752-758
pubmed: 33414250
J Clin Invest. 2015 Aug 3;125(8):3285-96
pubmed: 26193635
Nat Immunol. 2012 Jan 15;13(3):283-9
pubmed: 22245737
Sci Immunol. 2021 Jul 1;6(61):
pubmed: 34210785
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20428-33
pubmed: 19075244
Diabetes Technol Ther. 2020 Dec;22(12):948-953
pubmed: 32833543
Sci Transl Med. 2013 Jun 26;5(191):191ra82
pubmed: 23803704
Clin Exp Immunol. 2009 Feb;155(2):156-65
pubmed: 19040615
Diabetes Care. 2015 Oct;38(10):1964-74
pubmed: 26404926
Diabetologia. 2019 Apr;62(4):655-664
pubmed: 30569273
Lancet. 2011 Jul 30;378(9789):412-9
pubmed: 21719096
Nat Immunol. 2013 Dec;14(12):1212-8
pubmed: 24240160
Diabetes. 2008 Apr;57(4):1084-92
pubmed: 18252895
Nat Immunol. 2022 Jun;23(6):868-877
pubmed: 35618829